Vinaxanthone
CAS No. 133293-89-7
Vinaxanthone ( —— )
产品货号. M36359 CAS No. 133293-89-7
Vinaxanthone (SM-345431) 是一种有效的选择性 semaphorin3A、phospholipase C (PLC) 和 FabI 抑制剂,semaphorin3A 和 FabI的 IC50 分别为 0.1-0.2 μM 和 0.9 μM。Vinaxanthone 抑制底物(t-o-NAC thioester)和辅助因子 (NADPH),Ki 分别为 3.1 μM 和 1.0 μM。Vinaxanthone 能够用于处理由多重耐药病原体引起的感染。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥6831 | 有现货 |
|
| 10MG | ¥9196 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Vinaxanthone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Vinaxanthone (SM-345431) 是一种有效的选择性 semaphorin3A、phospholipase C (PLC) 和 FabI 抑制剂,semaphorin3A 和 FabI的 IC50 分别为 0.1-0.2 μM 和 0.9 μM。Vinaxanthone 抑制底物(t-o-NAC thioester)和辅助因子 (NADPH),Ki 分别为 3.1 μM 和 1.0 μM。Vinaxanthone 能够用于处理由多重耐药病原体引起的感染。
-
产品描述Vinaxanthone (SM-345431) is a potent and selective semaphorin3A, phospholipase C (PLC) and FabI inhibitor, with IC50s of 0.1-0.2 μM and 0.9 mM for semaphorin3A and FabI. Vinaxanthone inhibits the substrate (t-o-NAC thioester) and the cofactor (NADPH) with Kis of 3.1 μM and 1.0 μM, respectively. Vinaxanthone can be used to handle infections caused by multidrug-resistant pathogens.
-
体外实验Cell Viability AssayCell Line:mouse corneal epithelial cell line (TKE2)Concentration:0.1 mg/mL Incubation Time:24 hResult:Didn't affect cell viability by dose.Cell Proliferation Assay Cell Line: TKE2 Concentration:0.01-1 mg/mL Incubation Time:24 h Result:Showed a slight dose-dependent inhibition on cell proliferation.Immunofluorescence Cell Line:mouse podocytes Concentration:0.5 μM Incubation Time:20 min Result:Exhibited less C-Caspase3-positive cells.Western Blot Analysis Cell Line:HK-2 cells Concentration:0.1-1 μM Incubation Time:24 h Result:Decreased the expression of E-cadherin.Increased the expression of ɑ-SMA and vimentin.
-
体内实验Animal Model:murine corneal transplantation modelDosage:0.1 mg/mLAdministration: Subconjunctival injections, every 2 days, 3 weeks Result:Showed significantly higher nerve growth.Improved the corneal sensitivity.Animal Model: mouse model of Doxorubicin (10 mg/kg)-induced podocytopathy Dosage:20 μg Administration:Intraperitoneal injection (i.p.), every day Result:Improved the expression of nephrin.Reduced podocytopathy and tubular casts.Detected rarely TUNEL-positive cells in the Dox + Vinaxanthone group.Had fewer p-c-Jun-positive cells in the Dox + Vinaxanthone group.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Phospholipase
-
受体Phospholipase | Antibacterial
-
研究领域——
-
适应症——
化学信息
-
CAS Number133293-89-7
-
分子量576.42
-
分子式C28H16O14
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (173.48 mM; 超声助溶 )
-
SMILESC(C)(=O)C=1C(=C(C(C)=O)C=C2C1OC=3C(C2=O)=C(C(O)=O)C(O)=C(O)C3)C=4C(=O)C=5C(OC4)=CC(O)=C(O)C5C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Masahiro Aoki, et al. Structure of a novel phospholipase C inhibitor, vinaxanthone (Ro 09-1450), produced by penicillium vinaceum. Tetrahedron Letters. 1991, 32 (36):4737-4740.
产品手册
关联产品
-
Sodium stibogluconat...
葡萄糖酸锑钠是一种有效的蛋白酪氨酸磷酸酶抑制剂。
-
Compound 48/80 trihy...
Compound 48/80 trihydrochloride (C48/80 trihydrochloride) 是 N-甲基对甲氧基苯乙胺与甲醛缩合产物的混合物。Compound 48/80 trihydrochloride 也是一种组胺 (histamine) 释放剂和肥大细胞 (mast cell) 脱颗粒剂。Compound 48/80 trihydrochloride 抑制人血小板磷脂酰肌醇特异性磷脂酶 C (phosphatidylinositol-specific phospholipase C) 活性。
-
ML-299
ML-299 是一种双重 PLD1/2 抑制剂(PLD1 和 PLD2,IC50 分别为 6 nM、20 nM)。
021-51111890
购物车()
sales@molnova.cn

